Advanced search
Publication Cover
Gynecological Endocrinology Volume 39, 2023 - Issue 1
Submit an article Journal homepage
1,767
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Rapid reduction of adenomyosis coexisting with leiomyoma volume during treatment with Relugolix

Keitaro YamanakaDepartment of Obstetrics and Gynecology, Kobe University, Kobe City, JapanView further author information
,
Keiichi WashioDepartment of Obstetrics and Gynecology, Kobe University, Kobe City, JapanView further author information
,
Akiko UchidaDepartment of Obstetrics and Gynecology, Kobe University, Kobe City, JapanView further author information
,
Yuki SasagawaDepartment of Obstetrics and Gynecology, Kobe University, Kobe City, JapanView further author information
,
Masashi NishimotoDepartment of Obstetrics and Gynecology, Kobe University, Kobe City, JapanView further author information
,
Yui YamasakiDepartment of Obstetrics and Gynecology, Kobe University, Kobe City, JapanView further author information
,
Satoshi NagamataDepartment of Obstetrics and Gynecology, Kobe University, Kobe City, JapanView further author information
&
Yoshito TeraiDepartment of Obstetrics and Gynecology, Kobe University, Kobe City, JapanCorrespondence[email protected]
View further author information
 show all
Article: 2237121 | Received 09 May 2023, Accepted 10 Jul 2023, Published online: 03 Aug 2023

References

  • Naftalin J, Hoo W, Pateman K, et al. How common is adenomyosis? A prospective study of prevalence using transvaginal ultrasound in a gynaecology clinic. Hum Reprod. 2012;27(12):1–5. doi: 10.1093/humrep/des332.
  • Taran FA, Weaver AL, Coddington CC, et al. Understanding adenomyosis: a case control study. Fertil Steril. 2010;94(4):1223–1228. doi: 10.1016/j.fertnstert.2009.06.049.
  • Naftalin J, Hoo W, Pateman K, et al. Is adenomyosis associated with menorrhagia? Hum Reprod. 2014;29(3):473–479. doi: 10.1093/humrep/det451.
  • García-Solares J, Donnez J, Donnez O, et al. Pathogenesis of uterine adenomyosis: invagination or metaplasia? Fertil Steril. 2018;109(3):371–379. doi: 10.1016/j.fertnstert.2017.12.030.
  • Donnez J, Stratopoulou CA, Dolmans M-M. Uterine adenomyosis: from disease pathogenesis to a new medical approach using GnRH antagonists. Int J Environ Res Public Health. 2021;18:9941.
  • Vannuccini S, Luisi S, Tosti C, et al. Role of medical therapy in the management of uterine adenomyosis. Fertil Steril. 2018;109(3):398–405. doi: 10.1016/j.fertnstert.2018.01.013.
  • Osuga Y, Hayashi K, Kanda S. Long-term use of dienogest for the treatment of primary and secondary dysmenorrhea. J Obstet Gynaecol Res. 2020;46(4):606–617. doi: 10.1111/jog.14209.
  • Khan KN, Kitajima M, Hiraki K, et al. Cell proliferation effect of GnRH agonist on pathological lesions of women with endometriosis, adenomyosis and uterine myoma. Hum Reprod. 2010;25(11):2878–2890. doi: 10.1093/humrep/deq240.
  • Fawzy M, Mesbah Y. Comparison of dienogest versus triptorelin acetate in premenopausal women with adenomyosis: a prospective clinical trial. Arch Gynecol Obstet. 2015;292(6):1267–1271. doi: 10.1007/s00404-015-3755-5.
  • Bedaiwy MA, Mousa NA, Casper RF. Aromatase inhibitors prevent the estrogen rise associated with the flare effect of gonadotropins in patients treated with GnRH agonists. Fertil Steril. 2009;91(4 Suppl):1574–1577. doi: 10.1016/j.fertnstert.2008.09.077.
  • Osuga Y, Enya K, Kudou K, et al. Oral Gonadotropin-Releasing hormone antagonist relugolix compared with leuprorelin injections for uterine leiomyomas: a randomized controlled trial. Obstet Gynecol. 2019;133(3):423–433. doi: 10.1097/AOG.0000000000003141.
  • Taylor HS, Giudice LC, Lessey BA, et al. Treatment of Endometriosis-Associated pain with elagolix, an oral GnRH antagonist. N Engl J Med. 2017;377(1):28–40. doi: 10.1056/NEJMoa1700089.
  • Harada T, Osuga Y, Suzuki Y, et al. Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, reduces endometriosis-associated pain compared with leuprorelin in japanese women: a phase 3, randomized, double-blind, noninferiority study. Fertil Steril. 2022;117(3):583–592. doi: 10.1016/j.fertnstert.2021.11.013.
  • Donnez O, Donnez J. Gonadotropin-releasing hormone antagonist (linzagolix): a new therapy for uterine adenomyosis. Fertil Steril. 2020;114(3):640–645. doi: 10.1016/j.fertnstert.2020.04.017.
  • Bazot M, Daraï E. Role of transvaginal sonography and magnetic resonance imaging in the diagnosis of uterine adenomyosis. Fertil Steril. 2018;109(3):389–397. doi: 10.1016/j.fertnstert.2018.01.024.
  • Munro MG. Classification and reporting systems for adenomyosis. J Minim Invasive Gynecol. 2020;27(2):296–308. doi: 10.1016/j.jmig.2019.11.013.
  • Vannuccini S, Tosti C, Carmona F, et al. Pathogenesis of adenomyosis: an update on molecular mechanisms. Reprod Biomed Online. 2017;35(5):592–601. doi: 10.1016/j.rbmo.2017.06.016.
  • Bulun SE, Cheng Y-H, Yin P, et al. Progesterone resistance in endometriosis: link to failure to metabolize estradiol. Mol Cell Endocrinol. 2006;248(1-2):94–103. doi: 10.1016/j.mce.2005.11.041.
  • Yilmaz BD, Bulun SE. Endometriosis and nuclear receptors. Hum Reprod Update. 2019;25(4):473–485. doi: 10.1093/humupd/dmz005.
  • Kitawaki J, Kado N, Ishihara H, et al. Endometriosis: the pathophysiology as an estrogen-dependent disease. J Steroid Biochem Mol Biol. 2002;83(1-5):149–155. doi: 10.1016/s0960-0760(02)00260-1.
  • Khan KN, Kitajima M, Hiraki K, et al. Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy. Hum Reprod. 2010;25(3):642–653. doi: 10.1093/humrep/dep437.
  • Bulun SE. Uterine fibroids. N Engl J Med. 2013;369(14):1344–1355. doi: 10.1056/NEJMra1209993.
  • Matsushima T, Akira S, Yoneyama K, et al. Recurrence of uterine adenomyosis after administration of gonadotropin-releasing hormone agonist and the efficacy of dienogest. Gynecol Endocrinol. 2020;36(6):521–524. doi: 10.1080/09513590.2019.1683818.
  • Al-Hendy A, Lukes AS, Poindexter AN, 3rd, et al. Treatment of uterine fibroid symptoms with relugolix combination therapy. N Engl J Med. 2021;384(7):630–642. doi: 10.1056/NEJMoa2008283.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.